Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Science Signaling

• Publication date

  2017-08-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/scisignal.aak9702PMID 28851824PMCID PMC5851440
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting the TGFβ pathway for cancer therapy.

  2015cited by this paper
• Release of Active TGF-β1 from the Latent TGF-β1/GARP Complex on T Regulatory Cells Is Mediated by Integrin β8

  2014cited by this paper
• TGF-β activation and function in immunity.

  2014cited by this paper
• Combination of Alphavirus Replicon Particle–Based Vaccination with Immunomodulatory Antibodies: Therapeutic Activity in the B16 Melanoma Mouse Model and Immune Correlates

  2014cited by this paper
• New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape.

  2014cited by this paper
• Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction.

  2014cited by this paper
• Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma

  2013cited by this paper
• GITR Pathway Activation Abrogates Tumor Immune Suppression through Loss of Regulatory T-cell Lineage Stability

  2013cited by this paper
• Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies

  2013cited by this paper
• Molecular Pathways Molecular Pathways : Targeting the TGF-b Pathway for Cancer Therapy

  2012cited by this paper
• Molecular Mechanisms of Treg-Mediated T Cell Suppression

  2012cited by this paper
• Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment.

  2012cited by this paper
• Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype

  2012cited by this paper
• Detection of Intra-Tumor Self Antigen Recognition during Melanoma Tumor Progression in Mice Using Advanced Multimode Confocal/Two Photon Microscope

  2011cited by this paper
• Human Regulatory T Cells Rapidly Suppress T Cell Receptor–Induced Ca2+, NF-κB, and NFAT Signaling in Conventional T Cells

  2011cited by this paper
• Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion

  2011cited by this paper
• Monocytic CCR2+ Myeloid Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T Cell Infiltration Into the Tumor Microenvironment

  2011cited by this paper
• T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-β1 cytokine.

  2011cited by this paper
• Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.

  2010cited by this paper
• Agonist Anti-GITR Monoclonal Antibody Induces Melanoma Tumor Immunity in Mice by Altering Regulatory T Cell Stability and Intra-Tumor Accumulation

  2010cited by this paper
• CD8+ T cell concentration determines their efficiency in killing cognate antigen–expressing syngeneic mammalian cells in vitro and in mouse tissues

  2010cited by this paper
• IL-35-mediated induction of a potent regulatory T cell population

  2010cited by this paper
• Efficient Treg depletion induces T‐cell infiltration and rejection of large tumors

  2010cited by this paper
• Cancer esearch oenvironment and Immunology ctive Depletion of Foxp 3 + Regulatory T Cells roves Effective Therapeutic Vaccination R inst Established Melanoma

  2010cited by this paper
• OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis

  2009cited by this paper
• GARP (LRRC32) is essential for the surface expression of latent TGF-β on platelets and activated FOXP3+ regulatory T cells

  2009cited by this paper
• Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance.

  2007cited by this paper
• Tumorigenesis and Neoplastic Progression Caveolin-1 Is Critical for the Maturation of Tumor Blood Vessels through the Regulation of Both Endothelial Tube Formation and Mural Cell Recruitment

  2007cited by this paper
• CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells.

  2006cited by this paper
• Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation.

  2006cited by this paper
• A function for interleukin 2 in Foxp3-expressing regulatory T cells

  2005influential reference
• Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo

  2005cited by this paper
• Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo.

  2005cited by this paper
• Tolerance induced by inhaled antigen involves CD4(+) T cells expressing membrane-bound TGF-beta and FOXP3.

  2004cited by this paper
• Tolerance induced by inhaled antigen involves CD4+ T cells expressing membrane-bound TGF-β and FOXP3

  2004cited by this paper
• Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells

  2003cited by this paper
• Cell Contact–Dependent Immunosuppression by Cd4+Cd25+Regulatory T Cells Is Mediated by Cell Surface–Bound Transforming Growth Factor β

  2001cited by this paper
• Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells

  2001cited by this paper
• Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity

  1995cited by this paper
• T cell receptor antagonist peptides induce positive selection.

  1994influential reference
• Vascular Permeability Factor, Fibrin, and the Pathogenesis of Tumor Stroma Formation a

  1992cited by this paper

• A comprehensive review of mechanisms underlying resistance to immune checkpoint inhibitors

  2026cites this paper
• Regulating the regulators via targeting CD38 in the tumor microenvironment.

  2026cites this paper
• Intravital Imaging of Immune Responses in the Cancer Microenvironment

  2025cites this paper
• VIRMA promotes NSCLC progression by modifying ADAR m6A and increasing the activity of the TGF-β signaling pathway

  2025cites this paper
• Integrated analysis reveals an immune evasion prognostic signature for predicting the overall survival in patients with hepatocellular carcinoma

  2025cites this paper
• Abnormalities of primary and secondary hemostasis in multiple myeloma: insights from studies on thrombopoiesis, the coagulation system, and the bone marrow microenvironment

  2025cites this paper
• Clinical significance of the tumor microenvironment on immune tolerance in gastric cancer

  2025cites this paper
• Intra-tumoral sphingobacterium multivorum promotes triple-negative breast cancer progression by suppressing tumor immunosurveillance

  2025cites this paper
• Cytokine-driven cancer immune evasion mechanisms.

  2025cites this paper
• CCR2+ monocytes promote memory CD8+ T-cell differentiation via membrane-bound TGF-β

  2025cites this paper
• Interaction of intratumoral microbiota with the tumor immune microenvironment and its impact on cancer progression

  2025cites this paper
• The new era of immunotherapy for breast cancer: challenges and coping strategies of CAR-T cell therapy

  2025cites this paper
• Research Progress on the Tumor Microenvironment and Immunotherapy of Gastric Cancer

  2025cites this paper
• The role of heat shock proteins in tumorigenesis and their potential as targets for anti-tumor therapy.

  2025cites this paper
• The controversial role of senescence-associated secretory phenotype (SASP) in cancer therapy

  2025cites this paper
• Proteotoxic stress response drives T cell exhaustion and immune evasion

  2025cites this paper
• Mendelian Randomization in Conjunction with WGCNA Was Employed to Investigate the Potential Role of the Liver-Brain Axis in the Pathogenesis of Hepatocellular Carcinoma and Alzheimer’s Disease

  2025cites this paper
• Myeloid-Derived Suppressor Cells: Orchestrators of Tumor Immune Evasion and Therapeutic Vulnerabilities.

  2025cites this paper
• Tumor Microenvironmental Dynamics in Shaping Resistance to Therapeutic Interventions in Melanoma: A Narrative Review

  2025cites this paper
• TGFβ prevents IgE-mediated allergic disease by restraining T follicular helper 2 differentiation

  2024cites this paper
• Lactylation-driven TNFR2 expression in regulatory T cells promotes the progression of malignant pleural effusion

  2024cites this paper
• Prospects and challenges of immunotherapy for thyroid cancer.

  2024cites this paper
• Th17/Treg cell balance in patients with papillary thyroid carcinoma: a new potential biomarker and therapeutic target

  2024cites this paper
• Mechanistic studies of tumor-associated macrophage immunotherapy

  2024cites this paper
• Infiltrating treg reprogramming in the tumor immune microenvironment and its optimization for immunotherapy

  2024cites this paper
• Pharmacologic LDH inhibition redirects intratumoral glucose uptake and improves antitumor immunity in solid tumor models

  2024cites this paper
• TGF-β1 inhibitor enhances the therapeutic effect of microwave ablation on hepatocellular carcinoma

  2024cites this paper
• Intermittent MEK inhibition with GITR co-stimulation rescues T-cell function for increased efficacy with CTLA-4 blockade in solid tumor models.

  2024cites this paper
• Nanotechnology-based in situ cancer vaccines: Mechanisms, design, and recent advances

  2024cites this paper
• Bridging the divide: unveiling mutual immunological pathways of cancer and pregnancy

  2024cites this paper
• Th17 Cells: Orchestrators of Mucosal Inflammation and Potential Therapeutic Targets.

  2023cites this paper
• The progress of autoimmune hepatitis research and future challenges

  2023cites this paper
• Cancer-on-a-chip model shows that the adenomatous polyposis coli mutation impairs T cell engagement and killing of cancer spheroids

  2023cites this paper
• The Role of the Transforming Growth Factor-β Signaling Pathway in Gastrointestinal Cancers

  2023cites this paper
• Non-coding RNA in tumor-infiltrating regulatory T cells formation and associated immunotherapy

  2023cites this paper
• Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonists

  2023cites this paper
• Cytotoxic T Lymphocytes Control Growth of B16 Tumor Cells in Collagen–Fibrin Gels by Cytolytic and Non-Lytic Mechanisms

  2023cites this paper
• The protective and pathogenic role of Th17 cell plasticity and function in the tumor microenvironment

  2023cites this paper
• Vista of the Future: Novel Immunotherapy Based on the Human V-Set Immunoregulatory Receptor for Digestive System Tumors

  2023cites this paper
• Comprehensive analyses of a CD8+ T cell infiltration related gene signature with regard to the prediction of prognosis and immunotherapy response in lung squamous cell carcinoma

  2023cites this paper
• Mathematical modeling suggests cytotoxic T lymphocytes control growth of B16 tumor cells in collagin-fibrin gels by cytolytic and non-lytic mechanisms

  2023cites this paper
• TGF-β signaling pathway: Therapeutic targeting and potential for anti-cancer immunity.

  2023cites this paper
• Anti-GARP Antibodies Inhibit Release of TGF-β by Regulatory T Cells via Different Modes of Action, but Do Not Influence Their Function In Vitro

  2023cites this paper
• In vivo imaging of inflammatory response in cancer research

  2023cites this paper
• Liposomal Co-delivery of PD-L1 siRNA/Anemoside B4 for Enhanced Combinational Immunotherapeutic Effect.

  2022cites this paper
• TGF-β Regulation of T Cells

  2022cites this paper
• A novel immune prognostic model of non-M3 acute myeloid leukemia.

  2022cites this paper
• Systemic enhancement of antitumour immunity by peritumourally implanted immunomodulatory macroporous scaffolds

  2022cites this paper
• Radiotherapy induced immunogenic cell death by remodeling tumor immune microenvironment

  2022cites this paper
• Immunotherapy for lung cancer combining the oligodeoxynucleotides of TLR9 agonist and TGF-β2 inhibitor

  2022cites this paper
• Delivery strategies for ex vivo and in vivo T-cell reprogramming

  2022cites this paper
• Double Negative T Regulatory Cells: An Emerging Paradigm Shift in Reproductive Immune Tolerance?

  2022cites this paper
• Immunotherapy: Reshape the Tumor Immune Microenvironment

  2022cites this paper
• A deubiquitination module essential for Treg fitness in the tumor microenvironment

  2022cites this paper
• TGF-β and Cancer Immunotherapy.

  2022cites this paper
• Tumor Microenvironment and Hydrogel-Based 3D Cancer Models for In Vitro Testing Immunotherapies

  2022cites this paper
• Knowns and Unknowns about CAR-T Cell Dysfunction

  2022cites this paper
• High Expression of TGF-β1 Contributes to Hepatocellular Carcinoma Prognosis via Regulating Tumor Immunity

  2022cites this paper
• Megakaryocytes Are Regulators of the Tumor Microenvironment and Malignant Hematopoietic Progenitor Cells in Myelofibrosis

  2022cites this paper
• Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets

  2022influential citation
• The cellular and molecular basis of CD69 function in anti-tumor immunity.

  2022cites this paper
• Phosphorylation of SMAD3 in immune cells predicts survival of patients with early stage non-small cell lung cancer

  2021cites this paper
• Effects of CpG oligodeoxynucleotides on the differentiation of Treg/Th17 cells.

  2021cites this paper
• Mucosal thickening of the maxillary sinus is frequently associated with diffuse glioma patients and correlates with poor survival prognosis of GBM patients: comparative analysis to meningioma patients

  2021cites this paper
• Engineering the Immune Adaptor Protein STING as a Biologic

  2021cites this paper
• CAR-T in Cancer Treatment: Develop in Self-Optimization, Win-Win in Cooperation

  2021cites this paper
• TGF-β Signaling in Liver, Pancreas, and Gastrointestinal Diseases and Cancer

  2021cites this paper
• Cripto-1 as a Potential Target of Cancer Stem Cells for Immunotherapy

  2021cites this paper
• Phospholipase A2 Drives Tumorigenesis and Cancer Aggressiveness through Its Interaction with Annexin A1

  2021cites this paper
• Peripheral blood transcriptome heterogeneity and prognostic potential in lung cancer revealed by RNA‐Seq

  2021cites this paper
• Recent advances in the role of Th17/Treg cells in tumor immunity and tumor therapy

  2021cites this paper
• Targeting regulatory T cells for immunotherapy in melanoma

  2021cites this paper
• Synergies between therapeutic ultrasound, gene therapy and immunotherapy in cancer treatment.

  2021cites this paper
• In Situ Overexpression of Matricellular Mechanical Proteins Demands Functional Immune Signature and Mitigates Non-Small Cell Lung Cancer Progression

  2021cites this paper
• Combination strategies to maximize the benefits of cancer immunotherapy

  2021cites this paper
• CAR T cell therapy in solid tumors; with an extensive focus on obstacles and strategies to overcome the challenges.

  2021cites this paper
• Engineered T-cell Receptor T Cells for Cancer Immunotherapy

  2021cites this paper
• Role and Function of T Cell-Derived Exosomes and Their Therapeutic Value

  2021cites this paper
• Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: limitations and prospects: a systematic review

  2021cites this paper
• Tumor metastasis: Mechanistic insights and therapeutic interventions

  2021cites this paper
• Tumor Microenvironment in Pancreatic Intraepithelial Neoplasia

  2021cites this paper
• TGF-β-dependent Lymphoid Tissue Residency of Stem-like T cells Limits the Response to Tumor Vaccine

  2021cites this paper
• The role of transforming growth factor‐beta in immune suppression and chronic inflammation of squamous cell carcinomas

  2020cites this paper
• Mesenchymal Stem Cell–Derived Extracellular Vesicles Induce Regulatory T Cells to Ameliorate Chronic Kidney Injury

  2020cites this paper
• Structural basis for transcriptional coactivator recognition by SMAD2 in TGF-β signaling

  2020cites this paper
• Transforming Grown Factor-β Signaling in Immunity and Cancer

  2020cites this paper
• Treg-dependent immunosuppression triggers effector T cell dysfunction via the STING/ILC2 axis.

  2020cites this paper
• [Genetically modified regulatory T cells: therapeutic concepts and regulatory aspects].

  2020cites this paper
• Genetisch modifizierte regulatorische T-Zellen: Therapiekonzepte und ihr regulatorischer Rahmen

  2020cites this paper
• Reinvigorating exhausted CD8+ cytotoxic T lymphocytes in the tumor microenvironment and current strategies in cancer immunotherapy

  2020cites this paper
• TGFβ-Directed Therapeutics: 2020.

  2020cites this paper
• CAR-T in solid tumors: Blazing a new trail through the brambles.

  2020cites this paper
• Efficacy of the eribulin, pertuzumab, and trastuzumab combination therapy for human epidermal growth factor receptor 2–positive advanced or metastatic breast cancer: a multicenter, single arm, phase II study (JBCRG-M03 study)

  2020cites this paper
• Mechanisms of T-Cell Exhaustion in Pancreatic Cancer

  2020cites this paper
• TGF‐β2 interfering oligonucleotides used as adjuvants for microbial vaccines

  2020cites this paper
• Re-education of the Tumor Microenvironment With Targeted Therapies and Immunotherapies

  2020cites this paper
• Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects

  2020cites this paper
• Validation of Systemic and Local Tumour Immune Response to Eribulin Chemotherapy in the Treatment of Breast Cancer

  2020cites this paper
• Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology

  2020cites this paper
• Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances

  2020cites this paper